Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Aug 31, 2024 | (FY)Aug 31, 2023 | (FY)Aug 31, 2022 | (FY)Aug 31, 2021 | |
---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||
Cash from operating activities | -694.16%-147.44M | 84.01%-18.57M | 52.28%-116.09M | -243.24M |
Net profit before non-cash adjustment | -1,045.08%-178.04M | 111.63%18.84M | 52.52%-161.93M | ---341.07M |
Total adjustment of non-cash items | 37.62%16.15M | -19.33%11.74M | 1,168.44%14.55M | --1.15M |
-Depreciation and amortization | 64.32%4.25M | 5.81%2.58M | -20.74%2.44M | --3.08M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --2.48M |
-Assets reserve and write-off | 884.07%1.77M | -115.27%-226K | 36.53%1.48M | --1.08M |
-Disposal profit | --0 | --0 | 397.92%143K | ---48K |
-Net exchange gains and losses | 97.53%-41K | -327.75%-1.66M | --728K | --0 |
-Other non-cash items | -7.81%10.17M | 13.12%11.04M | 279.11%9.76M | ---5.45M |
Changes in working capital | 129.39%14.44M | -257.04%-49.14M | -67.63%31.29M | --96.68M |
-Change in receivables | -168.93%-72.58M | 71.22%-26.99M | -514.23%-93.79M | --22.64M |
-Change in payables | -5.57%2.78M | -95.49%2.94M | 655.37%65.31M | --8.65M |
-Change in accrued expense | 510.16%58.55M | -90.65%9.6M | 30.43%102.67M | --78.72M |
-Provision for loans, leases and other losses | 10,872.80%13.72M | --125K | --0 | ---- |
-Changes in other current assets | 73.46%-10.58M | -3.90%-39.87M | -126.79%-38.37M | ---16.92M |
-Changes in other current liabilities | 346.73%22.56M | 211.75%5.05M | -225.67%-4.52M | --3.6M |
Dividends paid (cash flow from operating activities) | ||||
Dividends received (cash flow from operating activities) | ||||
Interest paid (cash flow from operating activities) | 73.37%-2.56M | -5.22%-9.62M | -6.33%-9.14M | -8.6M |
Interest received (cash flow from operating activities) | 720.00%123K | 0.00%15K | 87.50%15K | 8K |
Tax refund paid | -0.43%-3.72M | -28.12%-3.7M | -147.98%-2.89M | 6.03M |
Other operating cash inflow (outflow) | -33.33%2K | -25.00%3K | 100.00%4K | 2K |
Operating cash flow | -381.95%-153.6M | 75.12%-31.87M | 47.89%-128.1M | ---245.81M |
Investing cash flow | ||||
Net PPE purchase and sale | 66.41%-2.83M | -6,524.43%-8.42M | 111.43%131K | ---1.15M |
Net intangibles purchase and sale | ---7.87M | ---- | ---- | ---1.96M |
Net business purchase and sale | ---285.76M | ---- | ---- | ---- |
Net investment product transactions | ---- | ---- | ---- | ---30M |
Net changes in other investments | 89.26%-281K | -544.58%-2.62M | -104.35%-406K | --9.32M |
Investing cash flow | -2,589.48%-296.73M | -3,912.00%-11.03M | 98.84%-275K | ---23.79M |
Financing cash flow | ||||
Net issuance payments of debt | 227.65%295M | -235.46%-231.11M | -272.23%-68.89M | --40M |
Net common stock issuance | --280.44M | --0 | 75.72%799.4M | --454.93M |
Issuance fees | ---- | ---3.71M | --0 | ---- |
Net other fund-raising expenses | ---4.52M | ---- | ---- | ---- |
Financing cash flow | 343.14%570.93M | -132.14%-234.82M | 47.60%730.51M | --494.93M |
Net cash flow | ||||
Beginning cash position | -15.66%1.49B | 51.80%1.76B | 32.33%1.16B | --877.32M |
Current changes in cash | 143.42%120.6M | -146.12%-277.72M | 167.21%602.13M | --225.34M |
Effect of exchange rate changes | -97.59%40K | 327.75%1.66M | ---728K | --0 |
Cash adjustments other than cash changes | ---- | 0.00%-1K | -100.00%-1K | --58.26M |
End cash Position | 8.12%1.61B | -15.66%1.49B | 51.80%1.76B | --1.16B |
Free cash flow | -307.81%-164.29M | 68.62%-40.29M | 48.45%-128.37M | ---249.01M |
Currency Unit | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |